P919: TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WITH ZOLEDRONIC ACID FOR FOUR YEARS INSTEAD OF TWO YEARS DECREASES RISK OF PROGRESSIVE BONE DISEASE WITHOUT INCREASING RISK OF OSTEONECROSIS OF THE JAW.

Bibliografiska uppgifter
Huvudupphovsmän:	Michael Gundesen, Fredrik Schjesvold, Annette Vangsted, Carsten Helleberg, Einar Haukås, Trine Silkjær, Elena Todorescu, Bo Amdi Jensen, Tobias S. Slørdahl, Jon Thor Asmussen, Hareth Nahi, Anders Waage, Niels Abildgaard, Thomas Lund
Materialtyp:	Artikel
Språk:	English
Publicerad:	Wiley 2023-08-01
Serie:	HemaSphere
Länkar:	http://journals.lww.com/10.1097/01.HS9.0000970580.01478.5b

Internet